Skip to content
Screener

Rapport Therapeutics, Inc. RAPP Price / sales

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.4×+0.4×
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
3.8×+1.1×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
461.8×—
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
149.5×-487×
Septerna, Inc. logo
Septerna, Inc.SEPN
14.9×-248×
Neuropace, Inc. logo
Neuropace, Inc.NPCE
4.4×-0.3×

Other financials

Income statement

See full
Revenue-—
Operating income-$60.8M-106%
Net income-$56.6M-112%
EPS (diluted)-$1.19-58.7%

Balance sheet

See full
Cash & equivalents$63.6M+15.5%
Total debt$10.1M-14.8%
Total equity$422.9M+60.5%
Total assets$459.0M+60.8%

Cash flow

See full
Operating cash flow-$41.5M-65.4%
CapEx$78.0K+255%
Free cash flow-$41.5M-65.5%

Valuation

See full
Market cap$2.22B+317%
Enterprise value$2.17B+343%

Profitability

See full
Operating margin-767.6%—
Net margin-685.8%—
FCF margin-485.7%—

Returns & leverage

See full
Return on equity-40%+22.3pp
Debt / equity0×0.0×
Current ratio15.7×-7.0×